JPY 796.0
(0.63%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 14.84 Billion JPY | 7.45% |
2022 | 13.81 Billion JPY | 5.58% |
2021 | 13.08 Billion JPY | 4.2% |
2020 | 12.56 Billion JPY | -51.07% |
2019 | 25.67 Billion JPY | 7.59% |
2018 | 23.86 Billion JPY | 8.96% |
2017 | 21.89 Billion JPY | 5.83% |
2016 | 20.69 Billion JPY | 14.21% |
2015 | 18.11 Billion JPY | 5.39% |
2014 | 17.19 Billion JPY | 3.6% |
2013 | 16.59 Billion JPY | 8.69% |
2012 | 15.26 Billion JPY | 11.39% |
2011 | 13.7 Billion JPY | 12.13% |
2010 | 12.22 Billion JPY | -0.07% |
2009 | 12.23 Billion JPY | 7.22% |
2008 | 11.4 Billion JPY | 15.92% |
2007 | 9.84 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 3.68 Billion JPY | 16.08% |
2023 Q3 | 3.84 Billion JPY | 2.54% |
2023 FY | 14.84 Billion JPY | 7.45% |
2023 Q1 | 3.83 Billion JPY | 12.08% |
2023 Q2 | 3.74 Billion JPY | -2.3% |
2023 Q4 | 3.42 Billion JPY | -10.94% |
2022 Q1 | 3.4 Billion JPY | 1.31% |
2022 FY | 13.81 Billion JPY | 5.58% |
2022 Q4 | 3.42 Billion JPY | -0.7% |
2022 Q3 | 3.44 Billion JPY | -3.01% |
2022 Q2 | 3.55 Billion JPY | 4.35% |
2021 Q4 | 3.35 Billion JPY | 2.94% |
2021 Q2 | 3.29 Billion JPY | 3.97% |
2021 Q3 | 3.26 Billion JPY | -1.0% |
2021 Q1 | 3.17 Billion JPY | -51.81% |
2021 FY | 13.08 Billion JPY | 4.2% |
2020 FY | 12.56 Billion JPY | -51.07% |
2020 Q3 | 6.73 Billion JPY | -2.56% |
2020 Q2 | 6.91 Billion JPY | 128.84% |
2020 Q1 | 3.02 Billion JPY | -53.45% |
2020 Q4 | 6.57 Billion JPY | -2.32% |
2019 Q4 | 6.48 Billion JPY | 2.01% |
2019 Q2 | 6.5 Billion JPY | 2.78% |
2019 FY | 25.67 Billion JPY | 7.59% |
2019 Q1 | 6.32 Billion JPY | 5.01% |
2019 Q3 | 6.35 Billion JPY | -2.17% |
2018 FY | 23.86 Billion JPY | 8.96% |
2018 Q3 | 5.99 Billion JPY | 0.28% |
2018 Q1 | 5.86 Billion JPY | 8.42% |
2018 Q4 | 6.02 Billion JPY | 0.42% |
2018 Q2 | 5.98 Billion JPY | 2.03% |
2017 Q1 | 5.37 Billion JPY | 57.22% |
2017 Q2 | 5.55 Billion JPY | 3.27% |
2017 FY | 21.89 Billion JPY | 5.83% |
2017 Q3 | 5.56 Billion JPY | 0.16% |
2017 Q4 | 5.4 Billion JPY | -2.8% |
2016 Q2 | 5.25 Billion JPY | 3.18% |
2016 FY | 20.69 Billion JPY | 14.21% |
2016 Q4 | 3.42 Billion JPY | -35.44% |
2016 Q3 | 5.29 Billion JPY | 0.9% |
2016 Q1 | 5.08 Billion JPY | 56.99% |
2015 Q1 | 4.81 Billion JPY | 60.6% |
2015 FY | 18.11 Billion JPY | 5.39% |
2015 Q4 | 3.24 Billion JPY | 0.0% |
2014 Q4 | 3 Billion JPY | -38.78% |
2014 FY | 17.19 Billion JPY | 3.6% |
2014 Q3 | 4.9 Billion JPY | 1.85% |
2014 Q2 | 4.81 Billion JPY | 7.39% |
2014 Q1 | 4.48 Billion JPY | 52.43% |
2013 Q2 | 4.51 Billion JPY | -1.51% |
2013 Q3 | 4.55 Billion JPY | 1.02% |
2013 Q4 | 2.93 Billion JPY | -35.53% |
2013 FY | 16.59 Billion JPY | 8.69% |
2013 Q1 | 4.58 Billion JPY | 77.53% |
2012 Q3 | 4.24 Billion JPY | -3.46% |
2012 Q4 | 2.58 Billion JPY | -39.13% |
2012 Q2 | 4.39 Billion JPY | 8.34% |
2012 FY | 15.26 Billion JPY | 11.39% |
2012 Q1 | 4.05 Billion JPY | 94.53% |
2011 Q2 | 4.03 Billion JPY | 6.3% |
2011 FY | 13.7 Billion JPY | 12.13% |
2011 Q1 | 3.79 Billion JPY | 81.13% |
2011 Q3 | 3.8 Billion JPY | -5.68% |
2011 Q4 | 2.08 Billion JPY | -45.17% |
2010 Q4 | 2.09 Billion JPY | -37.05% |
2010 FY | 12.22 Billion JPY | -0.07% |
2010 Q3 | 3.32 Billion JPY | -6.42% |
2010 Q2 | 3.55 Billion JPY | 7.5% |
2010 Q1 | 3.3 Billion JPY | 88.64% |
2009 Q3 | 3.48 Billion JPY | -4.78% |
2009 Q4 | 1.75 Billion JPY | -49.71% |
2009 Q1 | 3.33 Billion JPY | 122.21% |
2009 FY | 12.23 Billion JPY | 7.22% |
2009 Q2 | 3.65 Billion JPY | 9.72% |
2008 Q2 | 3.3 Billion JPY | 0.0% |
2008 Q3 | 3.68 Billion JPY | 11.7% |
2008 Q4 | 1.5 Billion JPY | -59.28% |
2008 FY | 11.4 Billion JPY | 15.92% |
2007 FY | 9.84 Billion JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
HEARTSEED INC | 1.8 Billion JPY | -722.85% |
Cawachi Limited | 58.2 Billion JPY | 74.49% |
Pharmarise Holdings Corporation | 7.53 Billion JPY | -97.093% |
Qol Holdings Co., Ltd. | 14.92 Billion JPY | 0.529% |
MatsukiyoCocokara & Co. | 278.39 Billion JPY | 94.667% |
Welcia Holdings Co., Ltd. | 326.87 Billion JPY | 95.458% |
Create SD Holdings Co., Ltd. | 85.11 Billion JPY | 82.556% |
NIHON CHOUZAI Co.,Ltd. | 48.09 Billion JPY | 69.129% |
COSMOS Pharmaceutical Corporation | 156.8 Billion JPY | 90.532% |
Tsuruha Holdings Inc. | 263.07 Billion JPY | 94.356% |
Satudora Holdings Co.,Ltd. | 20.92 Billion JPY | 29.047% |
Kusuri No Aoki Holdings Co., Ltd. | 99.52 Billion JPY | 85.082% |
Medical System Network Co., Ltd. | 44.09 Billion JPY | 66.329% |
Shinnihonseiyaku Co., Ltd. | 26.55 Billion JPY | 44.096% |
Sugi Holdings Co.,Ltd. | 192.21 Billion JPY | 92.276% |
YAKUODO HOLDINGS Co., Ltd. | 22.65 Billion JPY | 34.45% |
Astena Holdings Co., Ltd. | 14.04 Billion JPY | -5.719% |
Genky DrugStores Co., Ltd. | 28.6 Billion JPY | 48.098% |
Ain Holdings Inc. | 39.09 Billion JPY | 62.019% |
Sundrug Co.,Ltd. | 148.32 Billion JPY | 89.99% |